作者:
Joo Myung,Lee [1]
;
Seung Hun,Lee [1]
;
Doosup,Shin [2]
;
Ki Hong,Choi [1]
;
Tim P,van de Hoef [3]
;
Hyun Kuk,Kim [4]
;
Habib,Samady [5]
;
Tsunekazu,Kakuta [6]
;
Hitoshi,Matsuo [7]
;
Bon-Kwon,Koo [8]
;
William F,Fearon [9]
;
Javier,Escaned [10]
作者单位:
Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
[1]
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
[2]
Department of Clinical and Experimental Cardiology, Amsterdam UMC-University of Amsterdam, Amsterdam, the Netherlands.
[3]
Department of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine, Gwangju, Republic of Korea.
[4]
Andreas Gruentzig Cardiovascular Center, Emory University School of Medicine, Atlanta, Georgia, USA.
[5]
Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
[6]
Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.
[7]
Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
[8]
Division of Cardiovascular Medicine, Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
[9]
Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain.
[10]
关键词
CI, confidence intervalDES, drug-eluting stent(s)FFR, fractional flow reserveHR, hazard ratioMACE, major adverse cardiac event(s)NHPR, nonhyperemic pressure ratioPCI, percutaneous coronary interventionTVF, target vessel failureVOCE, vessel-related composite eventfractional flow reserveiFR, instantaneous wave-free ratioinstantaneous wave-free rationonhyperemic pressure ratiospercutaneous coronary interventionprognosis
DOI
10.1016/j.jacasi.2021.03.002
PMID
36338358
发布时间
2024-09-06